BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36951550)

  • 1. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
    Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
    Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
    Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
    Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of diseases and injuries attributable to alcohol consumption in the Middle East and North Africa region, 1990-2019.
    Safiri S; Nejadghaderi SA; Noori M; Sullman MJM; Collins GS; Kaufman JS; Kolahi AA
    Sci Rep; 2022 Nov; 12(1):19301. PubMed ID: 36369336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
    Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
    Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.
    Liu Y; Wang W; Huang X; Zhang X; Lin L; Qin JJ; Lei F; Cai J; Cheng B
    J Diabetes; 2022 Aug; 14(8):495-513. PubMed ID: 35924673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of pancreatic cancer and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
    Nejadghaderi SA; Kolahi AA; Noori M; Sullman MJM; Safiri S
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1535-1545. PubMed ID: 37218385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
    Wei H; Ren J; Li R; Qi X; Yang F; Li Q
    Front Endocrinol (Lausanne); 2024; 15():1379634. PubMed ID: 38601204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    GBD 2015 Risk Factors Collaborators
    Lancet; 2016 Oct; 388(10053):1659-1724. PubMed ID: 27733284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of Parkinson's disease in the Middle East and North Africa region, 1990-2019: results from the global burden of disease study 2019.
    Safiri S; Noori M; Nejadghaderi SA; Mousavi SE; Sullman MJM; Araj-Khodaei M; Singh K; Kolahi AA; Gharagozli K
    BMC Public Health; 2023 Jan; 23(1):107. PubMed ID: 36642724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
    Feizi H; Alizadeh M; Nejadghaderi SA; Noori M; Sullman MJM; Ahmadian Heris J; Kolahi AA; Collins GS; Safiri S
    Respir Res; 2022 Nov; 23(1):319. PubMed ID: 36403049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The burden of lower respiratory infections and their underlying etiologies in the Middle East and North Africa region, 1990-2019: results from the Global Burden of Disease Study 2019.
    Ashrafi-Asgarabad A; Bokaie S; Razmyar J; Akbarein H; Nejadghaderi SA; Carson-Chahhoud K; Sullman MJM; Kaufman JS; Safiri S
    BMC Pulm Med; 2023 Jan; 23(1):2. PubMed ID: 36600241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
    Li Z; Yang N; He L; Wang J; Ping F; Li W; Xu L; Zhang H; Li Y
    Diabetol Metab Syndr; 2023 Jan; 15(1):6. PubMed ID: 36647090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019.
    Li C; Hua G; Liu S; Yu H; Yang X; Liu L
    Diabetes Metab Res Rev; 2024 May; 40(4):e3802. PubMed ID: 38634501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of diseases attributable to excess body weight in the Middle East and North Africa region, 1990-2019.
    Nejadghaderi SA; Grieger JA; Karamzad N; Kolahi AA; Sullman MJM; Safiri S; Sabour S
    Sci Rep; 2023 Nov; 13(1):20338. PubMed ID: 37990049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019.
    Safiri S; Noori M; Nejadghaderi SA; Shamekh A; Karamzad N; Sullman MJM; Grieger JA; Collins GS; Abdollahi M; Kolahi AA
    Int J Eat Disord; 2023 Feb; 56(2):394-406. PubMed ID: 36301044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
    Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
    PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
    Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control.
    Bian Q; Zhang Y; Xue C; Lu W; Li W; Pan F; Li Y
    BMC Public Health; 2024 Mar; 24(1):782. PubMed ID: 38481192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis.
    Xie J; Liu Z; Ren L; He L; Lu S; Meng X; Zhang X; Su Z; Jing S; Shan T; Wang J; Xia R; Feng W; Li Y; Liu N; Liu Y
    BMC Public Health; 2023 Jul; 23(1):1361. PubMed ID: 37454041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of female breast cancer in the Middle East and North Africa region, 1990-2019.
    Safiri S; Noori M; Nejadghaderi SA; Sullman MJM; Bragazzi NL; Almasi-Hashiani A; Mansournia MA; Kolahi AA
    Arch Public Health; 2022 Jul; 80(1):168. PubMed ID: 35818086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.